Q1 2026 · 13F-HR
Ishara Investments LPholdings as filed
Filed 2026-05-15 · accession 0002111609-26-000002
$105.6M
Reported value
37
Positions
2026-03-31
Period end
The Brief · Ishara Investments LP · Q1 2026
AI · grounded in 13F
Ishara Investments LP initiated a new position in AXSM valued at $6.9M. The fund also added new stakes in Kalvista Pharmaceuticals Inc for $5.6M and ARWR for $3.5M. On the sell side, the fund closed its position in NUVB for $3.6M and exited BBIO for $2.8M. Additionally, the fund trimmed its holding in ANNX by 76.8%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $7.3M | 6.88% | 22,550 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $6.9M | 6.56% | 41,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $6.6M | 6.25% | 20,500 | PUT | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $5.9M | 5.63% | 1,025,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $5.6M | 5.27% | 276,750 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTIC | $5.3M | 5.05% | 369,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $4.6M | 4.39% | 82,000 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $4.3M | 4.11% | 820,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $3.7M | 3.46% | 174,250 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $3.5M | 3.29% | 55,350 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $3.3M | 3.16% | 57,400 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $3.3M | 3.12% | 82,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $3.3M | 3.11% | 110,700 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $3.2M | 3.08% | 174,250 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $2.9M | 2.72% | 1,230,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $2.8M | 2.67% | 57,400 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $2.7M | 2.59% | 123,000 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $2.7M | 2.56% | 451,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $2.2M | 2.10% | 82,000 | Common | SOLE |
| 372303206 | GMAB | GENMAB A/S | $2.2M | 2.08% | 82,000 | Common | SOLE |
| 23306J309 | DBVT | DBV TECHNOLOGIES S A | $2.1M | 2.03% | 102,500 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $2.0M | 1.92% | 82,000 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $2.0M | 1.87% | 49,200 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $1.9M | 1.76% | 142,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $1.7M | 1.61% | 5,125 | Common | SOLE |
| 53220K504 | LGND | LIGAND PHARMACEUTICALS INC | $1.6M | 1.55% | 8,200 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $1.5M | 1.47% | 49,200 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $1.5M | 1.43% | 153,750 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $1.4M | 1.33% | 902,000 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $1.4M | 1.29% | 57,400 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $1.3M | 1.23% | 102,500 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $1.2M | 1.12% | 36,900 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $965,345 | 0.91% | 174,250 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $819,672 | 0.78% | 24,600 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $740,435 | 0.70% | 140,500 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $698,333 | 0.66% | 10,250 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $269,370 | 0.26% | 820,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.